- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular insights on basal-like breast cancer
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 134, Issue 1, Pages 21-30
Publisher
Springer Nature
Online
2012-01-10
DOI
10.1007/s10549-011-1934-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
- (2010) Andrey I. Khramtsov et al. AMERICAN JOURNAL OF PATHOLOGY
- Synthetic Lethality through Combined Notch-Epidermal Growth Factor Receptor Pathway Inhibition in Basal-Like Breast Cancer
- (2010) Y. Dong et al. CANCER RESEARCH
- FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer
- (2010) P. S. Ray et al. CANCER RESEARCH
- Breast cancer precursors revisited: molecular features and progression pathways
- (2010) Maria A Lopez-Garcia et al. HISTOPATHOLOGY
- Clinicopathological features and treatment strategy for triple-negative breast cancer
- (2010) Yutaka Yamamoto et al. International Journal of Clinical Oncology
- Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies
- (2010) Daniel J. Toft et al. MOLECULAR ENDOCRINOLOGY
- Genomic instability in breast cancer: Pathogenesis and clinical implications
- (2010) Kevin A. Kwei et al. Molecular Oncology
- Biomarkers for Basal-like Breast Cancer
- (2010) Jennifer R. Choo et al. Cancers
- The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer
- (2009) H. Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Subtypes of familial breast tumours revealed by expression and copy number profiling
- (2009) Nic Waddell et al. BREAST CANCER RESEARCH AND TREATMENT
- CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification
- (2009) Pamela Klingbeil et al. BREAST CANCER RESEARCH AND TREATMENT
- Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome
- (2009) S Umemura et al. BRITISH JOURNAL OF CANCER
- Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
- (2009) S. E. Elsheikh et al. CANCER RESEARCH
- Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
- (2009) B. T. Hennessy et al. CANCER RESEARCH
- The Complex Relationship between BRCA1 and ER in Hereditary Breast Cancer
- (2009) J. J. Gorski et al. CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype
- (2009) Otto Walter et al. HUMAN PATHOLOGY
- Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a
- (2009) Feng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
- (2009) Leo A Niemeier et al. MODERN PATHOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer
- (2009) Xiao Yan Tang et al. PATHOLOGY RESEARCH AND PRACTICE
- Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity
- (2008) Giuseppe Viale et al. BREAST CANCER RESEARCH AND TREATMENT
- Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
- (2008) S E Elsheikh et al. BRITISH JOURNAL OF CANCER
- Analysis of Integrin 4 Expression in Human Breast Cancer: Association with Basal-like Tumors and Prognostic Significance
- (2008) S. Lu et al. CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- What is triple-negative breast cancer?
- (2008) William J. Irvin et al. EUROPEAN JOURNAL OF CANCER
- Basal cytokeratin expression in relation to biological factors in breast cancer
- (2008) Hajime Kuroda et al. HUMAN PATHOLOGY
- Basal-Like Breast Cancer: A Critical Review
- (2008) Emad A. Rakha et al. JOURNAL OF CLINICAL ONCOLOGY
- Nestin is expressed in basal-like and triple negative breast cancers
- (2008) S Parry et al. JOURNAL OF CLINICAL PATHOLOGY
- Impact of Basal-Like Breast Carcinoma Determination for a More Specific Therapy
- (2008) Emad A. Rakha et al. PATHOBIOLOGY
- CD109 expression in basal-like breast carcinoma
- (2008) Masaki Hasegawa et al. PATHOLOGY INTERNATIONAL
- Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers
- (2008) N. Dumont et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance
- (2008) Shunzo Kobayashi Breast Cancer
- αB-crystallin: A novel marker of invasive basal-like and metaplastic breast carcinomas
- (2007) Stephanie M. Sitterding et al. Annals of Diagnostic Pathology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started